FAAH inhibitor, PF-3845, Purity ≥98%

Synonym: 1196109-52-0; PF 3845; PF3845; N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide; N-(Pyridin-3-yl)-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzyl)piperidine-1-carboxamide; PF 3845 hydrate; N-Pyridin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide; FAAH inhibitor

MDL: MFCD21365072
CAS Number: 1196109-52-0
Compound CID: 25154867

Product Size

10 mg; 50 mg; 100 mg; 200 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

PF-3845, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting FAAH. The molecular weight of the compound is 456.46, and its molecular formula is C₂₄H₂₃F₃N₄O₂. It targets the FAAH.

Molecular Weight

456.46

Molecular Formula

C₂₄H₂₃F₃N₄O₂

Targets

FAAH

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 87 mg/mL (190.6 mM); Water: insoluble; Ethanol: 87 mg/mL (190.6 mM); In vivo: 30% propylene glycol, 5% Tween 80, 65% D5W, 14 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

PF-3845 can be studied extensively for its potential therapeutic applications in the treatment of autoimmune diseases, fibrosis, and other inflammatory conditions.